Literature DB >> 33619612

Liquid Crystalline Phases for Enhancement of Oral Bioavailability.

Xingwang Zhang1, Wei Wu2,3.   

Abstract

Liquid crystalline phases (LCPs) are generated upon lipolysis of ingested lipids in the gastrointestinal tract. The breaking off and subsequent evolution of LCPs produce more advanced vesicular and micellar structures which facilitate oral absorption of lipids, as well as co-loaded drug entities. Owing to sustained or controlled drug release, bioadhesiveness, and capability of loading drugs of different properties, LCPs are promising vehicles to implement for enhancement of oral bioavailability. This review aims to provide an overview on the classification, preparation and characterization, in vivo generation and transformation, absorption mechanisms, and encouraging applications of LCPs in enhancement of oral bioavailability. In addition, we comment on the merits of LCPs as oral drug delivery carriers, as well as solutions to industrialization utilizing liquid crystalline precursor and preconcentrate formulations.

Entities:  

Keywords:  cubosomes; drug delivery; hexosomes; in vivo fate; liquid crystalline phases; oral bioavailability

Mesh:

Substances:

Year:  2021        PMID: 33619612     DOI: 10.1208/s12249-021-01951-w

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  96 in total

Review 1.  Liquid crystalline drug delivery vehicles for oral and IV/subcutaneous administration of poorly soluble (and soluble) drugs.

Authors:  Andrew Otte; Bong-Kwan Soh; Gwangheum Yoon; Kinam Park
Journal:  Int J Pharm       Date:  2018-01-31       Impact factor: 5.875

2.  Multilayer-Coated Liquid Crystalline Nanoparticles for Effective Sorafenib Delivery to Hepatocellular Carcinoma.

Authors:  Raj Kumar Thapa; Ju Yeon Choi; Bijay K Poudel; Tran Tuan Hiep; Shiva Pathak; Biki Gupta; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim
Journal:  ACS Appl Mater Interfaces       Date:  2015-09-03       Impact factor: 9.229

Review 3.  Nanostructured liquid-crystalline particles for drug delivery.

Authors:  Alexandre Lancelot; Teresa Sierra; José Luis Serrano
Journal:  Expert Opin Drug Deliv       Date:  2014-02-03       Impact factor: 6.648

4.  Light controlled drug delivery containers based on spiropyran doped liquid crystal micro spheres.

Authors:  Gia Petriashvili; Lali Devadze; Tsisana Zurabishvili; Nino Sepashvili; Ketevan Chubinidze
Journal:  Biomed Opt Express       Date:  2016-01-11       Impact factor: 3.732

Review 5.  Current potential and challenges in the advances of liquid crystalline nanoparticles as drug delivery systems.

Authors:  Thiagarajan Madheswaran; Murugesh Kandasamy; Rajendran Jc Bose; Vengadeshprabhu Karuppagounder
Journal:  Drug Discov Today       Date:  2019-05-15       Impact factor: 7.851

Review 6.  Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins.

Authors:  Shakila B Rizwan; Ben J Boyd; Thomas Rades; Sarah Hook
Journal:  Expert Opin Drug Deliv       Date:  2010-10       Impact factor: 6.648

Review 7.  Controlling molecular transport and sustained drug release in lipid-based liquid crystalline mesophases.

Authors:  Alexandru Zabara; Raffaele Mezzenga
Journal:  J Control Release       Date:  2014-06-06       Impact factor: 9.776

Review 8.  Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.

Authors:  Rajan Rajabalaya; Muhammad Nuh Musa; Nurolaini Kifli; Sheba R David
Journal:  Drug Des Devel Ther       Date:  2017-02-13       Impact factor: 4.162

9.  Construction and Evaluation of Folic Acid-Modified 3-Bromopyruvate Cubosomes.

Authors:  Fangyan Hou; Hairong Wang; Yawen Zhang; Na Zhu; Hao Liu; Jianchun Li
Journal:  Med Sci Monit       Date:  2020-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.